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SexBackground: Sex-related electrocardiographic differences are a well-known phenomenon, but not their expres-
sion in patients with atrial ﬁbrillation (AF). In this study we aim to assess the presence of signiﬁcant sex-
related differences in ECG features, with particular attention to P-wave parameters, of a large cohort of patients
affected by different types of AF.
Methods: A 5-min resting 16-lead ECG was evaluated for 1119 AF patients in sinus rhythm. The durations of the
main ECGwaves and intervalsweremeasured for both atrial and ventricular activity. Moreover, the beat-to-beat
P-wave variability was computed for lead II and for the ﬁrst principal component (PC1) computed across the 16
leads. The percentage of variance explained by PC1 was computed.
Results: Males compared to females showed signiﬁcantly longer RR interval (1.02 ± 0.16 s vs 0.97 ± 0.15 s,
p b .001), PQ interval (191 ± 34 ms vs 183 ± 35 ms, p = .008), QRS duration (105 ± 17 ms vs 98 ± 13 ms,
p= .021), signiﬁcantly lower percentage of variance explained by PC1 and P-wave variability.Males with parox-
ysmal AF compared to females with paroxysmal AF had signiﬁcantly longer RR interval (1.01 ± 0.17 s vs 0.96 ±
0.14 s, p b .001), shorter QTc (388±27ms vs 402±27ms, p b .001), lower P-wave variability in PC1.Maleswith
persistent AF compared to females with persistent AF had signiﬁcantly shorter QTc interval (396 ± 30 ms vs
407 ± 26 ms, p= .019), longer PQ interval (194 ± 35 ms vs 182 ± 30 ms, p= .037), higher V1 terminal force
(2.1 ± 1.2 mV*ms vs 1.8 ± 1 mV*ms, p= .007), lower percentage of variance explained by PC1.
Conclusions:AF patients presentwith several sex-related ECG differences. Consequently, sex should be taken into
account when developing ECG algorithms identifying patients at risk for AF progression.
© 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Atrial ﬁbrillation (AF) is themost frequent clinical arrhythmia and is
associated with signiﬁcant costs, morbidity and reduced quality of life
[1]., Switzerland.
Auricchio).
eliability and freedom from bias
B.V. This is an open access article u
e, V.D.A. Corino, et al., Sex-rela
ardiology, https://doi.org/10.1Previous studies have reported several sex-related differences in the
prevalence, clinical presentation, associated comorbidities, and therapy
outcomes of patients with AF [2]. Firstly, the age-related prevalence of
AF is lower in women than in men. Secondly, women with AF have a
worse quality of life and aremore symptomatic thanmen [2].Moreover,
different studies have reported that female sex is an independent risk
factor for stroke, cardiovascular disease and death in patients with AF
[2,3]. Sex-related differences in relation with the susceptibility of AF
have been also reported. In contrast, very little is known about electro-
cardiographic (ECG) differences between men and women presenting
with different types of AF [4].nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2 R. Laureanti et al. / International Journal of Cardiology xxx (xxxx) xxxThe aim of this study was to assess the presence of signiﬁcant sex-
related differences in ECG features, with particular attention to P-
wave parameters, of a large cohort of patients affected by different
types of AF enrolled in the Swiss-AF study, a prospectively-designed co-
hort study [5].
2. Methods
2.1. Swiss-AF dataset
Swiss-AF is an observational cohort across 13 centers in Switzerland,
including 2415 patients with paroxysmal, persistent or permanent AF.
The study protocol, aims and patients' demographics have been re-
ported elsewhere [5]. In brief, at enrollment all patients underwent a
clinical examination, blood sampling, cerebral magnetic resonance im-
aging (cMRI), cognitive assessments, quality of life assessment and dis-
ability evaluation, AF-related medical resource use and costs. In
addition, a 5-min resting 16-lead ECG (the standard 12 leads plus 2 pre-
cordial right side leads and 2 precordial back leads)was recorded (sam-
ple rate: 1 kHz, signal bandwidth 0.04-387 Hzwith a resolution of 1 μV/
bit) using CS-200 Excellence and CS-200 Touch devices (Schiller AG,
Baar, Switzerland). Each procedure was repeated annually during
follow-up, except for blood sampling and cMRI that were repeated
every 2 years. The study protocol was approved by the local ethical
committees and informed written consent was obtained from each
participant.
2.2. ECG core laboratory
All recorded ECGs were stored at each participating center and then
uploaded to a central server. In this study, only the ECGs performed at
the time of enrollment were considered. A selection of 10 s of each
ECG signal was reviewed by two electrophysiologists (G.C. and A.A)
and classiﬁed according to the main rhythm present in the signal.
Rhythmwas classiﬁed as following: sinus rhythm (SR), atrial ﬁbrillation
(AF) or other rhythms (that included atrial tachycardia, atrial ﬂutter, or
rhythm induced by atrial pacing). During rating, the clinicians were
blinded to each other. In case of disagreement, adjudication was done
by consensus. Only the recordings during SR were analyzed in the pres-
ent study. Out of 1215 SR recordings, 96were excluded for the followingFig. 1. Rhythm classiﬁcation and workﬂow: a) Distribution of the patients in the three classes
baseline. b) At the beginning of analysis, 40 recordings were discarded for lack of data, poor
atrial analysis because the noise level did not allow P-wave analysis.
Please cite this article as: R. Laureanti, G. Conte, V.D.A. Corino, et al., Sex-rela
atrial ﬁbrillation..., International Journal of Cardiology, https://doi.org/10.1reasons: poor signal quality (N= 63), frequent supraventricular extra-
systoles (N= 6), incomplete clinical data (N=27). Patients with pace-
maker were included in the analysis only if they presented spontaneous
P-waves. The patientswere categorized into paroxysmal or persistent AF
following clinical diagnosis at enrollment (Fig. 1). Paroxysmal AFwas de-
ﬁned as AF that terminates spontaneously or with intervention within
7 days of onset. Persistent AF was deﬁned as AF that is sustained contin-
uously beyond 7 days [6]. A cardiac implantable electronic device (CIED)
was present in 109 patients (10%). The values of the ventricular param-
eters (RR, PQ, QRS, QTc) of these subjects were excluded from analysis.
Patients with CIED were included in the atrial analysis exclusively if
they presented with spontaneous P-waves.
2.3. ECG preprocessing
ECG was ﬁltered with a high-pass ﬁlter (Butterworth, 4th-order,
fc = 0.5 Hz) to reduce baseline wander, with a low-pass ﬁlter (FIR,
Hammingwindow, fc= 80Hz) to reduce high-frequency/muscle inter-
ferences andwith a Power Line Removal ﬁlter (50 Hz). Once beat detec-
tion was obtained by an algorithm similar to the Pan Tomkins' applied
on lead V5, where ventricular activity is more evident, ventricular and
atrial analysis were performed on averaged waveforms [7].
2.4. Ventricular analysis
In order to obtain an average beat, an alignment procedure was ap-
plied [8]. A beat window was deﬁned around the R peak from 50 ms to
500ms before and after the peak, respectively. A cross-correlation func-
tion was computed between each beat and all the others to evaluate
which beats were more representative of the recording. The 20 beats
with the highest cross-correlation mean value were averaged to obtain
a template. Each beatwas then correlatedwith the template and aligned
according to the lag at which the cross-correlation function was maxi-
mal. Only beats with a maximum cross-correlation coefﬁcient larger
than 0.8 were included in the further analysis. An average beat was
computed for each lead. In order to merge the information from all
the lead, a ventricular template (Vt) was deﬁned as in Eq. (1):
Vt ¼
XL
l¼1
M2l ð1Þof sinus rhythm, atrial ﬁbrillation and other rhythms, based on the prevailing rhythm at
signal quality, or supraventricular extra-systoles; other 56 were not considered in the
ted electrocardiographic differences in patientswith different types of
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3R. Laureanti et al. / International Journal of Cardiology xxx (xxxx) xxxwhere L is the number of leads, in this study L = 16, andMl is the aver-
age beat for the l-th lead computed as:
Ml ¼
1
N
XN
n¼1
Bn;l ð2Þ
where Bn,l is the n-th beat in the l-th lead andN is the overall number of
averaged beats (see Fig. S1 for details). The obtained Vtwas processed to
automatically detect the ﬁducial points. The averaging procedure was
performed to reduce the noise effect and to make detection of ﬁducial
points more reliable. QRS duration and QT interval were obtained as
the difference between the correspondent points. QTc was calculated
following the Bazett's formula [9], as in Eq. (3).
QTc ¼ QTﬃﬃﬃﬃﬃﬃ
RR
p ð3Þ
2.5. Atrial analysis
Knowing the average TQ and QRS durations from the ventricular
analysis, we could accurately select the segment containing the P-
wave, positioned after the end of the T wave and before the start of
the following QRS complex. The procedure to obtain an average P-
wave was similar to that described in section Ventricular analysis
but lead II was used. Lead II was chosen as P-waves are usually easily
identiﬁable and positive. After alignment, we obtained the 16 aver-
aged P-waves on which an automatic algorithm was applied to de-
tect the beginning and end of the P-waves. The P-wave duration
was computed as the difference between the median offset and the
median onset in the 16 leads (see Fig. S2 for details). The PQ interval
was computed on the template as the difference between the begin-
ning of the P-wave and the beginning of the following QRS complex.
The P-wave terminal force in lead V1 (V1 tf) was measured as the in-
tegral of the terminal negative part of the P-wave [10]. From the end
of the wave, the ﬁrst negative point (if present in the second half of
the wave) was found and considered the ending point of the integral.
Going backward, the ﬁrst not positive point was selected as the
starting point of the integral.
2.6. Waves detection
An algorithm was implemented to detect the ECG ﬁducial points.
The ﬁrst derivative was computed to ﬁnd the points with maximum
positive/negative slope. Based on the order of appearance, the concavity
of the wave was assessed. Two straight lines were drawn from the de-
tected points, with slopes that were a fraction of the ﬁrst derivative
value. The fraction, empirically chosen, changed according to the
assessed wave, going from 1/50 for the Q wave to 1/4 for the P and T
waves. The beginning and end points were identiﬁed as the points
with the maximal distance from the line (see Fig. S3 for details).
2.7. P-wave variability
P-wave variability was computed using 2 methods:
• the Euclidean distance between each beat and the following one, nor-
malized for the root mean square of the second one;
• the similarity index, computed as the cosine of the angle between
each beat and the following one [11].
To reduce the inﬂuence of noise, we excluded all the beats whose
maximum cross-correlation coefﬁcient with the average P-wave was
smaller than 0.9. The Euclidean distance and the similarity index were
computed for each beat and the mean and Median Absolute DeviationPlease cite this article as: R. Laureanti, G. Conte, V.D.A. Corino, et al., Sex-rela
atrial ﬁbrillation..., International Journal of Cardiology, https://doi.org/10.1(MAD) value of all the values were computed. This procedure was ap-
plied both on lead II and on the ﬁrst principal component (PC) [12].
The procedure was iterated beat to beat.
2.8. Principal component analysis
The principal component analysis (PCA) is a statistical method
to transform a set of possibly correlated variables into a set of un-
correlated ones (called principal components) by means of an or-
thogonal transformation [13]. The PCA is an iterative procedure
that derives step by step the component explaining the largest var-
iance inside the dataset, with the constraint of being orthogonal to
the preceding ones. This method is often used to reduce the dimen-
sionality of a dataset minimizing information loss by means of
selecting only few components that explain almost all the variation
present in the dataset [13]. In our study, we applied the PCA in
order to consider and synthesize the information of all the leads.
For the P variability, we computed the ﬁrst component of every
beat and measured its variation over time [11,12]. Furthermore,
we noted the percentage of variance expressed by the ﬁrst compo-
nent (called variance explained by PC1) and considered it a mea-
sure of the correlation between the morphological waves in the
16 leads. The mean and MAD values on the whole recording were
computed.
2.9. Statistical analysis
A general linear model was run to determine the effect of gender
on the computed parameters after controlling for the following co-
variates: age, height, weight, class of AF, history of coronary artery
disease, of pulmonary vein ablation, of sleep apnea, of diabetes and
of thyroid disease. The procedure was performed for the whole pop-
ulation and in subgroups with the same type of AF. Furthermore, a
general linear model was run to determine the effect of AF type on
the computed parameters after adjusting for sex, age, height,
weight, history of heart failure, transient ischemic attack (TIA), anti-
coagulant drugs (OAC/DOAC, that stand for, respectively, oral anti-
coagulants and direct-acting oral anticoagulants), amiodarone and
antiarrhythmic drugs Ic (AADs). After adjustment for the previously
stated covariates, the adjusted p-values are reported in the results,
whereas data are unadjusted mean and standard deviation. For the
categorical variables, the two-proportion z-test was used to com-
pare the populations.
A p-value b.05 was considered statistically signiﬁcant. All analyses
were performed usingMatlab R2017a (TheMathWorks, Natick,MA). Sta-
tistical analysis was performed using SPSS v.25.0 (IBMCorp., Armonk, NY,
USA).
3. Results
3.1. Study population features
Out of 2415 participants, 2403 had an ECG recording available at the
ﬁrst visit. Among them, 1215 showed SR asmain rhythm andwere thus
analyzed for the purpose of this study (Fig. 1).
Baseline characteristics of the study population are shown in Table 1.
Male predominance was observed (766 males, 69%). Males were signif-
icantly younger as compared to females (70 ± 9 vs. 73 ± 8 years,
p b .001). Moreover, males were more frequently affected by persistent
AF compared to females (34% vs. 28%, p = .031). No signiﬁcant differ-
enceswere found in the rate ofmales and females treatedwith Ic antiar-
rhythmic drugs. Patients with paroxysmal AF received more frequently
Ic AADs, while patients with persistent AF were treated more often
with amiodarone. Regarding the history of interventions to restore
sinus rhythm, we found that 31.6% of paroxysmal patients and 37.3%
of persistent ones had at least one ablation of the pulmonary veins;ted electrocardiographic differences in patientswith different types of
016/j.ijcard.2019.12.053
Table 1
Study population characteristics: values are given as average (std) or number (%). The asterisks mark the statistically signiﬁcant differences.
Study population
Characteristics All
N = 1119
Males
N = 766
Females
N = 353
p-value
males vs. females
Paroxysmal
N = 762
Persistent
N = 357
p-value
paroxysmal vs. persistent
Males 766 (68.5%) 766 (100%) 0 (0%) – 506 (66.4%) 260 (72.8%) 0.028*
Age 70.8 (8.5) 69.7 (8.6) 73.1 (7.9) b0.001* 71.2 (8.5) 70.0 (8.5) 0.030*
Height [cm] 172.5 (9.0) 176.4 (6.8) 163.9 (6.8) b0.001* 172.1 (8.9) 173.3 (9.2) 0.027*
Weight [Kg] 81.5 (15.8) 85.2 (14.4) 73.6 (15.8) b0.001* 80.7 (15.8) 83.1 (15.6) 0.019*
BMI [Kg/m2]
Class of AF:
27.4 (4.7) 27.3 (4.3) 27.4 (5.6) 0.862 27.2 (4.8) 27.6 (4.5) 0.228
- Paroxysmal 762 (68.1%) 506 (66.1%) 256 (72.5%) 0.031* 762 (100%) 0 (0%) –
- Persistent 357 (31.9%) 260 (33.9%) 97 (27.5%) 0.031* 0 (0%) 357 (100%) –
AF duration [months] 54.3 (68.7) 54.3 (64.9) 54.1 (76.4) 0.966 55.6 (69.5) 51.4 (66.9) 0.347
History of:
- Coronary Artery Disease 274 (24.5%) 224 (29.2%) 50 (14.2%) b0.001* 185 (24.3%) 89 (24.9%) 0.813
- Valvular Disease 89 (8.0%) 61 (8.0%) 28 (7.9%) 0.986 57 (7.5%) 32 (9.0%) 0.393
- Heart Failure 188 (16.8%) 129 (16.8%) 59 (16.7%) 0.974 102 (13.4%) 86 (24.1%) b0.001*
- PV ablation 374 (33.4%) 277 (36.2%) 97 (27.5%) 0.003* 241 (31.6%) 133 (37.3%) 0.067
- Sleep Apnea 131 (11.7%) 114 (14.9%) 17 (4.8%) b0.001* 86 (11.3%) 45 (12.6%) 0.528
- Hypertension 725 (64.8%) 482 (62.9%) 243 (68.8%) 0.051 480 (63.0%) 245 (68.6%) 0.062
- Diabetes 144 (12.9%) 109 (14.2%) 35 (9.9%) 0.034* 101 (13.3%) 43 (12.0%) 0.574
- Peripheral Artery Disease 65 (5.8%) 50 (6.5%) 15 (4.2%) 0.103 46 (6.0%) 19 (5.3%) 0.634
- Renal Failure 170 (15.2%) 110 (14.4%) 60 (17.0%) 0.258 114 (15.0%) 56 (15.7%) 0.759
- Thyroid Disease 147 (13.1%) 69 (9.0%) 78 (22.1%) b0.001* 93 (12.2%) 54 (15.1%) 0.192
- Stroke 115 (10.3%) 79 (10.3%) 36 (10.2%) 0.948 85 (11.2%) 30 (8.4%) 0.144
- TIA 82 (7.3%) 51 (6.7%) 31 (8.8%) 0.223 66 (8.7%) 16 (4.5%) 0.005*
- Previous CIED 109 (9.7%) 65 (8.5%) 44 (12.5%) 0.037* 78 (10.2%) 31 (8.7%) 0.414
Drug therapy:
- OAC/DOAC 963 (86.1%) 657 (85.8%) 306 (86.7%) 0.682 638 (83.7%) 325 (91.0%) b0.001*
- Amiodarone 254 (22.7%) 177 (23.1%) 77 (21.8%) 0.631 136 (17.8%) 118 (33.1%) b0.001*
- Digitalis 15 (1.3%) 10 (1.3%) 5 (1.4%) 0.881 7 (0.9%) 8 (2.2%) 0.124
- Ic AAD 79 (7.1%) 54 (7.0%) 25 (7.1%) 0.984 65 (8.5%) 14 (3.9%) 0.001*
- Beta Blockers 721 (64.4%) 484 (63.2%) 237 (67.1%) 0.195 491 (64.4%) 230 (64.4%) 0.997
-Calcium Antagonist 213 (19.0%) 144 (18.8%) 69 (19.5%) 0.767 139 (18.2%) 74 (20.7%) 0.324
4 R. Laureanti et al. / International Journal of Cardiology xxx (xxxx) xxx18.1% of paroxysmal subjects and 76.2% of persistent ones had at least
one electrical cardioversion; 16.1% of paroxysmal patients and 22.7% of
persistent subjects had at least one radiofrequency ablation of theTable 2
Comparison Male/Female and Paroxysmal/Persistent: values are given as average (std). The as
Study population
Characteristics All
N = 1119
Males
N = 766
Females
N = 353
RR [ms] 1000 (160) 1015 (164) 968 (146)
QRS [ms] 103 (16) 105 (17) 98 (13)
QTc [ms] 395 (29) 391 (28) 404 (27)
PQ [ms] 189 (35) 191 (34) 183 (35)
P dur [ms] 122 (21) 123 (21) 120 (22)
V1 tf [mV*ms] 2.1 (1.1) 2.2 (1.2) 2.0 (1.0)
Mean of the beat-to-beat
EuclDist Lead II
33.5×10−2
(11.6×10−2)
33.4×10−2
(11.6× 10−2)
0.33.6×10−2
(11.7×10−2)
MAD of the beat-to-beat
EuclDist Lead II
5.4 ×10−2
(1.9 ×10−2)
5.4 ×10−2
(1.9 ×10−2)
5.4 ×10−2
(1.9 ×10−2)
Mean of the beat-to-beat
similarity Lead II
94.3 ×10−2
(3.6 ×10−2)
94.3 ×10−2
(3.6 ×10−2)
94.3 ×10−2
(3.6 ×10−2)
MAD of the beat-to-beat
similarity Lead II
1.6 ×10−2
(1.0 ×10−2)
1.6 ×10−2
(0.9 ×10−2)
1.6 ×10−2
(1.0 ×10−2)
Mean of the e×plained
variance by PC1
74.2 (10.2) 73.8 (10.3) 75.2 (9.9)
MAD of the e×plained
variance by PC1
2.06 (0.90) 2.05 (0.88) 2.08 (0.94)
Mean of the beat-to-beat
EuclDist PC1
23.4 ×10−2
(9.8 ×10−2)
22.8 ×10−2
(9.6 ×10−2)
24.7 ×10−2
(10.1 ×10−2)
MAD of the beat-to-beat
EuclDist PC1
4.7 ×10−2
(2.1 ×10−2)
4.6 ×10−2
(2.1 ×10−2)
4.9 ×10−2
(2.2 ×10−2)
Mean of the beat-to-beat
similarity PC1
97.0 ×10−2
(2.3 ×10−2)
97.1 ×10−2
(2.3 ×10−2)
96.8 ×10−2
(2.4 ×10−2)
MAD of the beat-to-beat
similarity PC1
1.0 ×10−2
(0.8 ×10−2)
1.0 ×10−2
(0.8 ×10−2)
1.1 ×10−2
(0.8 ×10−2)
V1 tf stands for V1 terminal force; EuclDist stands for Euclidean Distance;MAD stands for medi
Please cite this article as: R. Laureanti, G. Conte, V.D.A. Corino, et al., Sex-rela
atrial ﬁbrillation..., International Journal of Cardiology, https://doi.org/10.1isthmus region. The time from the ﬁrst AF diagnosis to the patients' en-
rollment was comparable between males and females and between pa-
tients with paroxysmal and persistent AF.terisks mark the statistically signiﬁcant differences.
p-value males vs.
females
Paroxysmal
N = 762
Persistent
N = 357
p-value paroxysmal vs.
persistent
b0.001* 995 (159) 1012 (161) 0.119
0.021* 102 (16) 104 (18) 0.072
0.050 393 (28) 399 (30) 0.122
0.008* 188 (35) 191 (34) 0.219
0.083 121 (20) 124 (24) 0.056
0.415 2.2 (1.1) 2.0 (1.1) 0.088
0.795 33.2 ×10−2
(11.8×10−2)
34.1 ×10−2
(11.3×10−2)
0.206
0.740 5.3 ×10−2
(1.9 ×10−2)
5.5 ×10−2
(1.8 ×10−2)
0.181
0.999 94.4 ×10−2
(3.6 ×10−2)
94.1 ×10−2
(3.6 ×10−2)
0.186
0.736 1.6 ×10−2
(1.0 ×10−2)
1.7×10−2
(0.9 ×10−2)
0.181
0.011* 73.9 (10.2) 75 (10.1) 0.078
0.623 2.05 (0.91) 2.07 (0.88) 0.936
0.046* 23.3×10−2
(9.8 ×10−2)
23.7 ×10−2
(9.8 ×10−2)
0.480
0.093 4.7 ×10−2
(2.2 ×10−2)
4.8 ×10−2
(2.1 ×10−2)
0.693
0.395 97.0 ×10−2
(2.3 ×10−2)
96.9 ×10−2
(2.3 ×10−2)
0.478
0.429 1.0 ×10−2
(0.8 ×10−2)
1.0 ×10−2
(0.8 ×10−2)
0.495
an absolute value; PC1 stands for ﬁrst principal component.
ted electrocardiographic differences in patientswith different types of
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ECG features according to patients' sex are shown in the Table 2.
Males presented with signiﬁcantly longer RR (1.02 ± 0.16 s vs 0.97 ±
0.15 s, p b .001), PQ interval (191 ± 34 ms vs 183 ± 35 ms, p= .008),
QRS duration (105 ± 17 ms vs 98 ± 13 ms, p= .021), after adjusting
for clinical covariates (see Fig. S4). Among the whole population, 12%
of males and 5% of women had a spontaneous QRS interval longer
then 120 ms. Females presented with signiﬁcantly higher mean of the
beat-to-beat Euclidean distance in the ﬁrst PC ([24.7 ± 10.1] x 10−2
vs [22.8 ± 9.6] x 10−2, p= .046) and percentage of variance explained
by the ﬁrst PC (75.2 ± 9.9 vs 73.8 ± 10.3, p = .011), as depicted in
Fig. S5. As shown in Fig. S6, the frequency distribution of P wave dura-
tion was similar in males and females. In 13.5% of male and 15% female
patients the P wave duration was equal or shorter than 100 ms.
3.3. Sub-analysis according to the clinical type of AF
ECG parameters of patients with paroxysmal and persistent AF are
shown in Table 2. After adjusting for covariates, no signiﬁcant difference
was found between paroxysmal and persistent AF both in the whole
population and in the subgroups of males and females.
When considering the clinical type of AF for males and females sep-
arately, similar results to the whole population were obtained, even if
less signiﬁcative comparisons were found (see Table 3). In particular,
in the subgroup of paroxysmal AF, males compared to females had sig-
niﬁcantly longer RR interval (1.01 ± 0.17 s vs 0.96 ± 0.14 s, p b .001),
shorter QTc (388 ± 27 ms vs 402 ± 27 ms, p b .001), and lower P-
wave variability in PC1. Among the persistent patients, males compared
to females had signiﬁcantly shorter QTc interval (396± 30ms vs 407±
26ms, p= .019), longer PQ interval (194± 35ms vs 182± 30ms, p=
.037), higher V1 terminal force (2.1 ± 1.2 mV*ms vs 1.8 ± 1 mV*ms,
p = .007), and lower percentage of variance explained by PC1. While
the PQ duration and the V1 terminal force were found signiﬁcantly dif-
ferent only in the persistent group, the trend was also present in the
paroxysmal subset.Table 3
Comparison Male/Female in paroxysmal and persistent subgroups: values are given as average
Study population
Characteristics Males
Paroxysmal
N = 506
Females Paroxysmal
N = 256
p-value
paroxysm
paroxysm
RR [ms] 1010 (165) 963 (141) b0.001*
QRS [ms] 104 (16) 98 (14) 0.058
QTc [ms] 388 (27) 402 (27) b0.001*
PQ [ms] 190 (34) 184 (37) 0.055
P dur [ms] 122 (19) 120 (22) 0.225
V1 tf [mV*ms] 2.2 (1.2) 2.0 (1.1) 0.068
Mean of the beat-to-beat
EuclDist Lead II
32.8 ×10−2 (11.8 ×10−2) 33.8 ×10−2 (11.8 ×10−2) 0.300
MAD of the beat-to-beat
EuclDist Lead II
5.2 ×10−2 (1.9 ×10−2) 5.5 ×10−2 (2.0 ×10−2) 0.150
Mean of the beat-to-beat
similarity Lead II
94.4 ×10−2 (3.6 ×10−2) 94.3 ×10−2 (3.6 ×10−2) 0.571
MAD of the beat-to-beat
similarity Lead II
1.5 ×10−2 (1.0 ×10−2) 1.6 ×10−2 (1.0 ×10−2) 0.244
Mean of the e×plained
variance by PC1
73.6 (10.3) 74.3 (10.2) 0.302
MAD of the e×plained
variance by PC1
2.0 (0.9) 2.1 (1.0) 0.189
Mean of the beat-to-beat
EuclDist PC1
22.5 ×10−2 (9.6 ×10−2) 24.8 ×10−2 (10.0 ×10−2) 0.048*
MAD of the beat-to-beat
EuclDist PC1
4.6 ×10−2 (2.2 ×10−2) 4.9 ×10−2 (2.2 ×10−2) 0.059
Mean of the beat-to-beat
similarity PC1
97.2×10−2
(2.2 ×10−2)
96.7 ×10−2 (2.4 ×10−2) 0.212
MAD of the beat-to-beat
similarity PC1
0.9 ×10−2 (0.8 ×10−2) 1.1 ×10−2 (0.8 ×10−2) 0.396
V1 tf stands for V1 terminal force; EuclDist stands for Euclidean Distance;MAD stands for medi
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To our knowledge, this is the ﬁrst study assessing sex-related ECG
features in patients with different types of AF. The main ﬁndings of
our analysis are: 1) patients with AF present with signiﬁcant sex-
related ECG differences; 2) these differences affect numerous parame-
ters of both atrial and ventricular activity, such as the RR interval, QRS
duration, PQ interval, mean of the beat-to-beat Euclidean distance in
the ﬁrst PC and percentage of variance explained by the ﬁrst PC;
3) ECG parameters show differences between males and females inside
each AF type subgroup.4.1. ECG sexual differences in patients with AF
Sex-related differences in ECG signals are a well-known phenome-
non [14]. Indeed, in the general population the corrected QT interval
(QTc) is signiﬁcantly longer in females than males. Furthermore, it has
been shown that the development of this sex-related behavior is related
with the age and hormonal factors. In fact, while male and female have
similar QT values during childhood, after puberty and throughout early
adulthood QT interval becomes shorter in males until returning to fe-
male values around the age of 50 years [14]. Regarding atrial parame-
ters, there is, instead, no clear correlation between estrogens and P
wave characteristics. Dogan et al. found that P-wave parameters did
not change in postmenopausal women when compared to premeno-
pausal women [15]. Karabag et al. found signiﬁcant differences for P-
wave dispersion and the minimal P-wave duration according to the
phase of menstrual cycle. However, even if they found an inverse rela-
tion between estrogen levels and P-wave dispersion, the correlation be-
tween them was not statistically signiﬁcant [16]. Parikh et al. studied
the effects of reproductive period duration and number of pregnancies
on midlife ECG indices, reporting small but signiﬁcant changes in P-
wave characteristics. However, they also stated that many factors
could contribute to this behavior, thus the role of sex hormones is not
clear [17].(std). The asterisks mark the statistically signiﬁcant differences.
al males vs.
al females
Males
Persistent
N = 260
Females Persistent
N = 97
p-value
persistent males vs.
persistent females
1024 (161) 980 (158) 0.257
106 (19) 98 (12) 0.178
396 (30) 407 (26) 0.019*
194 (35) 182 (30) 0.037*
125 (23) 122 (24) 0.284
2.1 (1.2) 1.8 (1.0) 0.007*
34.5 ×10−2 (11.2 ×10−2) 33.1 ×10−2 (11.5 ×10−2) 0.298
5.6 ×10−2 (1.8 ×10−2) 5.2 ×10−2 (1.8 ×10−2) 0.110
94.0 ×10−2 (3.6 ×10−2) 94.3 ×10−2 (3.6 ×10−2) 0.463
1.7 ×10−2 (0.9 ×10−2) 1.6 ×10−2 (0.9 ×10−2) 0.275
74.2 (10.4) 77.4 (8.9) 0.044*
2.1 (0.9) 2.0 (0.9) 0.231
23.4 ×10−2 (9.6 ×10−2) 24.6 ×10−2 (10.4 ×10−2) 0.275
4.7 ×10−2 (2.1 ×10−2) 4.8 ×10−2 (2.2 ×10−2) 0.837
96.9 ×10−2 (2.4 ×10−2) 96.9 ×10−2 (2.2 ×10−2) 0.900
1.0 ×10−2 (0.8 ×10−2) 1.0 ×10−2 (0.8 ×10−2) 0.703
an absolute value; PC1 stands for ﬁrst principal component.
ted electrocardiographic differences in patientswith different types of
016/j.ijcard.2019.12.053
6 R. Laureanti et al. / International Journal of Cardiology xxx (xxxx) xxxIn this study, different ECG parameters were evaluated in relation to
the patient's sex to better characterize sex-related differences in AF pa-
tients. Similar to previous studies, our analysis conﬁrms the existence of
sexual differences regarding RR interval and QRS duration between
males and females affected by AF.
The sex-related difference in the RR duration has already been re-
ported in the literature, but the explanation is still not univocally shared.
Salama andBett report that thehigher heart rate likely reﬂects an intrin-
sic difference, as women have higher vagal tone and lower heart rate
variability than men [18]. Burke et al. compared males and females be-
fore and after an autonomic blockade and proved that the difference ap-
pears to be associated with a gender difference in exercise capacity
rather than intrinsic gender related properties of the sinus node or dif-
ferences in autonomic tone [19]. Beckers et al. state that the difference
in RR between males and females is probably due to a mix of factor,
such as: difference in the sympathetic and vagal modulation, hormones
and physical characteristics, stroke volume [20].While a shorter QRS for
women is reported in literature [21], there is no consensus on the phys-
iological reasons behind. Simonson et al. considered it a possible effect
of smaller heart dimensions in women [22]. However, Hnatkova et al.
reported that QRS duration seems to be independent of lean body
mass and also likely independent of heart sizes. They speculated that
QRS shortening in women could be caused at the myocytes level by dif-
ferences in the distribution of ion channels [23].
There was no signiﬁcant difference in QTc interval after adjust-
ment for covariates, probably due to the high average age of the pop-
ulation (71 ± 9 years) that suggests a less important role of sexual
hormones. In a previous study focusing on sex-related ECG differ-
ences in healthy young athletes, longer P-wave duration and PQ in-
terval were observed in males [24]. It was also reported that sex
differences of ECG features were not completely explained by varia-
tions in body size. Consistent with a recent report by Nielsen et al.
14% of our patients showed a P wave duration of 100 ms or less,
being more frequent in women than men [25]. In the Copenhagen
ECG study, patients with very short P wave (b90 ms) were mostly fe-
male, had a particularly high risk of developing atrial ﬁbrillation,
stroke, and risk of cardiovascular death as high as those patients
with prolonged P wave N120 ms. The mechanism postulated by Niel-
sen et al. was that a more rapid conduction time may provide a sub-
strate for reentry in the early stages of the arrhythmia, related to
electrical and structural remodeling. However, our population was
on average 15 years older than the ECG Copenhagen cohort, had an
history of paroxysmal or persistent atrial ﬁbrillation and many
were on antiarrhythmic drugs. Therefore, it is possible that these pa-
tients have different electrophysiological properties possibly related
to still unknown genetic variants. Differently from previous studies,
we also assessed sex differences in the beat-to-beat P-wave morpho-
logical variability (beat-to-beat Euclidean distance, similarity and
percentage of variance explained by ﬁrst principal component
among leads), a set of indexes connected to the probability of AF
onset and worsening [26]. These indexes are based on the assump-
tion that AF patients sustain electrophysiological and/or structural
remodeling of the atria, leading to a more chaotic propagation of
the signal [27]. It has been reported that these indexes may be valu-
able in identifying patients prone to paroxysmal AF [25–27]. Recent
computer modeling work by Pezzuto et al. indicated that beat-to-
beat variability is related to presence and quantity of heterogeneous
conduction, in combination with the intrinsic variability in the earli-
est activation site location in the sino-atrial node [28]. In our study,
the mean of the beat-to-beat Euclidean distance in the ﬁrst PC was
signiﬁcantly higher in the female population, suggesting a higher de-
gree of ﬁbrosis. Possible indirect clinical conﬁrmation of that has
been found by Li et al. who observed higher degree of ﬁbrotic atrial
remodeling in women compared to men [29]. This result is interest-
ing considering that no signiﬁcant differences emerged in the dura-
tion of the AF between males and females.Please cite this article as: R. Laureanti, G. Conte, V.D.A. Corino, et al., Sex-rela
atrial ﬁbrillation..., International Journal of Cardiology, https://doi.org/10.14.2. ECG features of patients with different types of AF
The identiﬁcation of the clinical stage of AF (pathology progression)
and the discrimination between paroxysmal and persistent AF is of ut-
most importance while assessing the therapeutic strategy and subse-
quent outcomes. Nearly all previous studies have focused on the
identiﬁcation of AF susceptibility or have correlated P-wave morphol-
ogy to prognosis, but only few studies have analyzed sex-related ECG
differences among patients with different clinical types of AF in SR
[30]. Differently from these studies, Swiss-AF cohort included patients
with known paroxysmal and persistent AF.We computed some indexes
reported in the literature as related to the risk of AF, such as QRS dura-
tion, P-wave duration, PQ interval and beat-to-beat P-wave variability
[26,31]. This was based on the consideration that the progression from
the paroxysmal to the persistent type of AF could elicit ECG abnormali-
ties and differences similar to those present between healthy subjects
and patients with AF. El-Chami et al. found an association between
QRS prolongation and AF susceptibility in patients with left ventricular
dysfunction; they suggested that a longer QRS could reﬂect a general-
ized higher myocardial ﬁbrosis, providing the substrate for AF [31].
Moreover, a prolonged QT interval has often been associatedwith an in-
creased risk of AF [32]. The underlying pathophysiologicalmechanism is
not clear: Mandyam et al. suggested that this observation could be re-
lated to aberrations in the refractoriness of both atrium and ventricle
or to enhanced activity of the late sodium channel [32].
Regarding P-wave characteristics, we hypothesized that the beat-to-
beat P-wave variability is able not only to predict and detect AF epi-
sodes, but also to differentiate between different types of AF, supposing
that the progression of AF corresponds to a higher remodeling and con-
sequent P-wavemorphological variability. P-waveduration, PQ interval,
P-wave terminal force in V1 and beat-to-beat P-wave variability have
often been associatedwith the risk of AF and are considered a surrogate
of higher atrial conduction time, due to either atrial enlargement or
slower conduction [10,26].
Neither ventricular-related parameters, nor P-wave characteristics
were able to discriminate patients with different types of AF in the stud-
ied population. A possible explanation is related to the different drug
therapies used when the patient is known to suffer from paroxysmal
or persistent AF.
The parameters showing a signiﬁcantly different behavior between
males and females in the whole population had a similar trend when
comparing males to females in the paroxysmal and persistent groups
(see Table 3). For the PQ interval, we found a signiﬁcant difference be-
tweenmales and females in the whole population and in the persistent
subgroup. Even if this difference was not statistically signiﬁcant in the
paroxysmal group, the trend is however present. The PQ interval is usu-
ally longer inmen [33]. Furthermore, its prolongation is also linkedwith
higher risk of AF in men. In women, instead, a higher risk of AF is linked
with both short and long PQ [34]. Since the studied population consists
of AF patients, we expect a longer PQ in men in comparison to both
women and men without AF. For the female population we expect a
shorter PQ than men and a PQ duration falling in the tails of the physi-
ological range of female population: indeed 4% of men and 8% of
women had a PQ shorter than the 5th percentile of the whole PQ distri-
bution. We found a signiﬁcant males/females difference in the persis-
tent group, when AF is more stable and so men are more likely to
have a prolonged PQ, while in women the presence of both short and
long PQs lowers the average for the female population.
5. Limitations
Our study has certain limitations. It was conducted in a population of
patients with heterogeneous clinical characteristics, which included
fewerwomen thanmen, diminishing the statistical power of the analysis.
This study included only AF patients in SR. This could lead to an un-
derrepresentation of patients in advanced disease and explain whyted electrocardiographic differences in patientswith different types of
016/j.ijcard.2019.12.053
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AF. Moreover, the time needed to return in SR was not available in all
patients. Therefore, it was not possible to differentiate between early-
persistent and long-standing persistent AF.
We did not have information about the presence of bundle branch
block in the ECGs, limiting the signiﬁcance of the QRS duration analysis.
Sex-related P-wave parameters were not assessed in a control group
of healthy patients without AF. Some parameters were not available at
the time of the study, such as left atriumdimension. Finally, no informa-
tion on the progression of AF from baseline to visit 1 were available.
6. Conclusions
Patients with AF present with signiﬁcant SR sex-related ECG parame-
ters differences. Consequently, sex should be taken into accountwhende-
veloping ECG algorithms identifying patients at risk for AF progression.
Supplementary data to this article can be found online at https://doi.
org/10.1016/j.ijcard.2019.12.053.
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